Chemical entities that kill senescent cells for use in treating age-related disease
US10195213B2 · kind B2 · utility
13Cited by
34References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 14, 2016 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Mar 14, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/541
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.